Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,599 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696

Conditions
Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

NCT04080284

Conditions
Cancer of the Endometrium, Endometrial Cancer, Endometrial Carcinoma, +14 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Rutgers NJ School of Medicine Newark, New Jersey, United States
  • Imbert Cancer Center Northwell Health Bay Shore, New York, United States
  • Greenlawn Cancer Institute, Northwell Health Greenlawn, New York, United States
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

NCT02327078

Conditions
Adnexal Diseases, Astrocytoma, B-cell Malignancies, +53 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCSF - University of California San Francisco San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935

Conditions
Adnexal Diseases, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +32 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • USA Mitchell Cancer Center Mobile, Alabama, United States
  • UC Davis - Comprehensive Cancer Centre Sacramento, California, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View Trial Details

Related conditions